ENDLOS-TURBO PUT - BIOGEN IDEC | Market Closed - Boerse Frankfurt Warrants 03:35:14 2024-05-24 pm EDT | ||
| 13.41 EUR | +0.15% |
|
| Current month | -3.59% | ||
| 1 month | -11.05% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 13.44 | +0.37% |
| 24-05-23 | 13.39 | +5.18% |
| 24-05-22 | 12.73 | +1.92% |
| 24-05-21 | 12.49 | +2.55% |
| 24-05-20 | 12.18 | -0.57% |
Real-time Boerse Frankfurt Warrants
Last update May 24, 2024 at 03:35 pm EDT
More quotesStatic data
| Product type | Warrant Knock-Out senza Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ7M6A |
| ISIN | DE000DJ7M6A5 |
| Date issued | 2023-12-15 |
| Strike | 360.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 9.412 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.29 € |
|---|---|
| Lowest since issue | 8.62 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
217.8
USD
Average target price
286.1
USD
Spread / Average Target
+31.33%
- Stock Market
- Certificates
- Certificat
